CNTMF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
37.62M
CRLBF
Price
$1.20
Change
+$0.06 (+5.26%)
Updated
Sep 5 closing price
Capitalization
424.65M
61 days until earnings call
Interact to see
Advertisement

CNTMF vs CRLBF

Header iconCNTMF vs CRLBF Comparison
Open Charts CNTMF vs CRLBFBanner chart's image
FLUENT
Price$0.06
Change-$0.00 (-0.00%)
Volume$58.26K
Capitalization37.62M
Cresco Labs
Price$1.20
Change+$0.06 (+5.26%)
Volume$613.99K
Capitalization424.65M
CNTMF vs CRLBF Comparison Chart in %
Loading...
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTMF vs. CRLBF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTMF is a Hold and CRLBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CNTMF: $0.06 vs. CRLBF: $1.20)
Brand notoriety: CNTMF and CRLBF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CNTMF: 20% vs. CRLBF: 44%
Market capitalization -- CNTMF: $37.62M vs. CRLBF: $424.65M
CNTMF [@Pharmaceuticals: Generic] is valued at $37.62M. CRLBF’s [@Pharmaceuticals: Generic] market capitalization is $424.65M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTMF’s FA Score shows that 0 FA rating(s) are green whileCRLBF’s FA Score has 0 green FA rating(s).

  • CNTMF’s FA Score: 0 green, 5 red.
  • CRLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, CRLBF is a better buy in the long-term than CNTMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTMF’s TA Score shows that 3 TA indicator(s) are bullish while CRLBF’s TA Score has 4 bullish TA indicator(s).

  • CNTMF’s TA Score: 3 bullish, 6 bearish.
  • CRLBF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than CNTMF.

Price Growth

CNTMF (@Pharmaceuticals: Generic) experienced а -2.94% price change this week, while CRLBF (@Pharmaceuticals: Generic) price change was -20.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($425M) has a higher market cap than CNTMF($37.6M). CRLBF YTD gains are higher at: 31.330 vs. CNTMF (-18.351). CRLBF has higher annual earnings (EBITDA): 136M vs. CNTMF (-423K). CRLBF has more cash in the bank: 147M vs. CNTMF (26.2M). CNTMF has less debt than CRLBF: CNTMF (133M) vs CRLBF (631M). CRLBF has higher revenues than CNTMF: CRLBF (685M) vs CNTMF (105M).
CNTMFCRLBFCNTMF / CRLBF
Capitalization37.6M425M9%
EBITDA-423K136M-0%
Gain YTD-18.35131.330-59%
P/E RatioN/AN/A-
Revenue105M685M15%
Total Cash26.2M147M18%
Total Debt133M631M21%
FUNDAMENTALS RATINGS
CNTMF vs CRLBF: Fundamental Ratings
CNTMF
CRLBF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
6435
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNTMF's Valuation (62) in the null industry is in the same range as CRLBF (79). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

CNTMF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (95) in the null industry is in the same range as CNTMF (99). This means that CRLBF’s stock grew similarly to CNTMF’s over the last 12 months.

CRLBF's Price Growth Rating (35) in the null industry is in the same range as CNTMF (64). This means that CRLBF’s stock grew similarly to CNTMF’s over the last 12 months.

CNTMF's P/E Growth Rating (97) in the null industry is in the same range as CRLBF (100). This means that CNTMF’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNTMFCRLBF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CNTMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PPTCX17.150.04
+0.23%
Virtus KAR Global Quality Dividend C
JEMWX37.17N/A
N/A
JPMorgan Emerging Markets Equity R6
EADIX18.37-0.02
-0.11%
Eaton Vance Global Equity Income A
GQHIX13.31-0.04
-0.30%
GQG Partners US Quality Value Fund Ins
NSRKX25.53-0.08
-0.31%
Northern World Selection Index K

CNTMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTMF has been loosely correlated with TCNNF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTMF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTMF
1D Price
Change %
CNTMF100%
-1.82%
TCNNF - CNTMF
47%
Loosely correlated
+4.55%
VRNOF - CNTMF
38%
Loosely correlated
+5.51%
GTBIF - CNTMF
37%
Loosely correlated
+4.55%
CURLF - CNTMF
36%
Loosely correlated
+1.79%
CRLBF - CNTMF
34%
Loosely correlated
+5.26%
More

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TCNNF. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+5.26%
TCNNF - CRLBF
75%
Closely correlated
+4.55%
TSNDF - CRLBF
75%
Closely correlated
+13.08%
CURLF - CRLBF
73%
Closely correlated
+1.79%
VRNOF - CRLBF
72%
Closely correlated
+5.51%
GTBIF - CRLBF
71%
Closely correlated
+4.55%
More